Sagheer Ahmed

Dr. Sagheer Ahmed

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SASagheer Ahmed
Sagheer Ahmed
SKSidrah Tariq Khan
Sidrah Tariq Khan
KZKazim Zargaham
Kazim Zargaham
AKArif-ullah Khan
Arif-ullah Khan
SKSaeed Khan
Saeed Khan
Ahmed Al-HarrasiAhmed Al-Harrasi
Ahmed Al-Harrasi
Alzheimer's disease (AD), is the most common type of dementia primarily affecting the later years of life. Its prevalence is likely to increase in any aging population and will be a major burden on healthcare system by the mid of the century. Despite scientific and technological breakthroughs in the last 50 years, that have expanded our understanding of the disease on a system, cellular and molecular level, therapies that could stop or slow the progression of the disease are still unavailable. The Food and Drug Administration (FDA), has approved acetylcholinesterase (AChE) inhibitors (donepezil, galantamine, tacrine and rivastigmine) and glutamate receptor antagonist (memantine) for the treatment of AD. In this review we summarize the studies reporting phytocompounds and extracts from medicinal plants that show AChE inhibitory activities and could be of potential benefit in AD. Future research directions are suggested and recommendations made to expand the use of medicinal plants and their formulations to prevent, mitigate and treat AD.

8 April 2021 in Plants
Verified
Journal Article
Open access
PDF file
MMMahwish Mahwish
Mahwish Mahwish
FSFarhan Saeed
Farhan Saeed
MSMuhammad Tauseef Sultan
Muhammad Tauseef Sultan
ARAyesha Riaz
Ayesha Riaz
SASagheer Ahmed
Sagheer Ahmed
RMRosana Mihaela Manea
Rosana Mihaela Manea
Natural products are gaining clinical significance in modern day health care systems to prevent diseases. Bitter melon, a health promoting vegetable, is traditionally used for medical nutrition therapy to cure diabetes but to reap maximum health claims, vigilant control of its substances in diet is crucial as part of curative action for effective diabetes management. In the present research, first phase focused on detection of key bioactive components, i.e., charantin and vicine in different parts of its fruit. In the second phase, normal and hyperglycemic Sprague Dawley rats were fed on skin, flesh and whole fruit of bitter melon at 150 and 300 mg/kg body weight and assessed for diabetes prophylaxis and treatment. The highest amount of charantin (0.16 ± 0.02 mg/g) was recorded in flesh while vicine was present in abundance in whole fruit (0.21 ± 0.01 μg/100 g). In normal rats, bitter melon supplementation was helpful in managing the onset of diabetes. Hyperglycemic rats showed diabetic complications including polydipsia, polyuria, glycosuria, renal hypertrophy and increased glomerular filtration rate. However, bitter melon consumption showed significant improvements in these parameters. The most potent dose was 300 mg/kg whole fruit that resulted in 31.64% lowering of blood glucose level and 27.35% increase in insulin level in hyperglycemic rats.

1 January 2022 in Bioengineered
Verified
Journal Article
Open access
NUNasr Ullah
Nasr Ullah
Abrar HussainAbrar Hussain
Abrar Hussain
SASagheer Ahmed
Sagheer Ahmed
MRMahmood Rasool
Mahmood Rasool
ASAbdul Jabbar Shah
Abdul Jabbar Shah
DNA methylation is a process in which methyl (CH3) groups are added to the DNA molecule. The DNA segment does not change in the sequence, but DNA methylation could alter the action of DNA. Different enzymes like DNA methyltransferases (DNMTs) take part in methylation of cytosine/adenine nucleosides in DNA. In prokaryotes, DNA methylation is performed to prevent the attack of phage and also plays a role in the chromosome replication and repair. In fungi, DNA methylation is studied to see the transcriptional changes, as in insects, the DNA methylation is not that well-known, it plays a different role like other organisms. In mammals, the DNA methylation is related to different types of cancers and plays the most important role in the placental development and abnormal DNA methylation connected with diseases like cancer, autoimmune diseases, and rheumatoid arthritis. Graphical abstract

29 July 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
SASagheer Ahmed
Sagheer Ahmed
SKSaeed Khan
Saeed Khan
Imran ImranImran Imran
Imran Imran
FMFadwa AL Mughairbi
Fadwa AL Mughairbi
FSFahad Sultan Sheikh
Fahad Sultan Sheikh
Ahmed Al-HarrasiAhmed Al-Harrasi
Ahmed Al-Harrasi
As per the World Health Organization (WHO), more than 288 vaccines against COVID-19 are being developed, with an estimated 184 being presently investigated in the pre-clinical phases, while 104 of these vaccine candidates are at various stages of clinical trials. Twelve of these are in the advanced stages of clinical investigation, and promising results in the phase 3 trials have already paved the way for their regulatory approval and subsequent dissemination for global use. Preliminary and interim results of some of these candidate vaccines are being analyzed for public dissemination. Some of these vaccines have already been rolled out to immunize not only the highest risk individuals but also the general population in several countries. Once their safety and efficacy are established, the next limiting step would be their mass manufacturing by the pharmaceutical companies to fulfill the global demand. The challenge of manufacturing billions of doses of high-quality vaccines is under-appreciated at the moment. A massive vaccination drive would be needed to protect people of all ages. The timely and coordinated execution of the vaccination effort would require unprecedented coordination at the national and international levels for generating funds to purchase the required doses of vaccines, fair distribution of doses and managing the mechanics of delivering vaccines throughout the world.

1 October 2021 in Neurochemistry International
Verified
Journal Article
Closed access
SKSidrah Tariq Khan
Sidrah Tariq Khan
SASagheer Ahmed
Sagheer Ahmed
SGSaima Gul
Saima Gul
Ajmal KhanAjmal Khan
Ajmal Khan
Ahmed Al-HarrasiAhmed Al-Harrasi
Ahmed Al-Harrasi

1 January 2021 in Bioengineered
Verified
Journal Article
Open access
MRMahmood Rasool
Mahmood Rasool
AMArif Malik
Arif Malik
SWSulayman Waquar
Sulayman Waquar
QAQura Tul Ain
Qura Tul Ain
RRRabia Rasool
Rabia Rasool
MHMohammed Hamdard
Mohammed Hamdard
Colorectal cancer (CRC) is graded as one of the most common cancer. It accounts for the second leading cause of cancer deaths worldwide. The present study intends to investigate the role and importance of different biochemical variables in the development of colorectal cancer. In this cross-sectional study we recruited ninety-one patients diagnosed with colorectal cancer and fifty-three age-sex matched controls from June 2017 to June 2018. Different variables i.e. SOD, GSH, CAT, MDA, TGF, VEGF, TNF, ILs, MMPs, etc., were estimated with the help of their respective methods. Our findings suggest a significant increase in the levels of different inflammatory and stress-related markers. The NFκB, TGF-β, VEGFβ, 8OHdG, IsoP-2α were significantly found to be increased in patients with colon cancer (0.945 ± 0.067 μg/ml, 18.59 ± 1.53 pg/ml, 99.35 ± 4.29 pg/ml, 21.26 ± 1.29 pg/ml, 102.25 ± 4.25 pg/ml) as compared to controls (0.124 ± 0.024 μg/ml, 8.26 ± 0.88 pg/ml, 49.58 ± 2.62 pg/ml, 0.93 ± 0.29 pg/ml, 19.65 ± 3.19 pg/ml). Notably, the levels of different antioxidants were shown to be significantly lower in patients of colon cancer. The present study concluded that excessive oxidative stress and lipid peroxidation result in a decrease in the antioxidative capacity of cells which may influence diverse signaling cascades including NF-KB, which results in DNA modification and gene transcription that ultimately involved in the progression of colon cancer. Graphical Abstract